• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-15与RAE-1ɛ协同作用,刺激CD8(+) T细胞的非T细胞受体依赖性增殖和活化。

IL-15, in synergy with RAE-1ɛ, stimulates TCR-independent proliferation and activation of CD8(+) T cells.

作者信息

Qian Li, Zhang Yue, Pan Xin-Yuan, Ji Ming-Chun, Gong Wei-Juan, Tian Fang

机构信息

Department of Immunology, School of Medicine, Yangzhou University, Yangzhou 225001.

出版信息

Oncol Lett. 2012 Feb;3(2):472-476. doi: 10.3892/ol.2011.495. Epub 2011 Nov 25.

DOI:10.3892/ol.2011.495
PMID:22740934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3362349/
Abstract

CD8(+) T cells play critical roles in immunosurveillance by killing malignant or virally infected cells. Interleukin 15 (IL-15) is a critical cytokine for promoting proliferation and the effector capacity of CD8(+) T cells, and has been used to support the growth of CD8(+) T cells in cellular therapies of neoplastic diseases. Recent studies have shown that IL-15, in synergy with other cytokines, such as IL-6, enhances the T-cell receptor (TCR)-independent proliferation and function of CD8(+) T cells. The aim of the present study was to investigate the role of BaF3-mb15-RAE cells in stimulating mouse CD8(+) T cells. BaF3 cells were cultured and B16F10 cells were grown in DMEM. MTT assay was used to detect the proliferation of CD8(+) T cells. Cells were analyzed using flow cytometry. The results showed that IL-15 synergistically acts with another T-cell stimulatory molecule, RAE1ɛ, to potently promote the proliferation of CD8(+) T cells, induce CD8(+) T-cell activation and enhance granzyme B and interferon-γ (IFN-γ) production in the absence of signaling via the TCR. Moreover, IL-15 in combination with RAE1ɛ resulted in a cooperative effect on CD8(+) T-cell-mediated cytotoxicity against B16F10 tumor cells. Thus, results of the present study showed that IL-15, in synergy with RAE1ɛ, enhances the TCR-independent effector function of CD8(+) T cells in vitro, which may be useful in the cellular immunotherapy of cancer.

摘要

CD8(+) T细胞通过杀伤恶性或病毒感染细胞在免疫监视中发挥关键作用。白细胞介素15(IL-15)是促进CD8(+) T细胞增殖和效应能力的关键细胞因子,已被用于支持肿瘤疾病细胞治疗中CD8(+) T细胞的生长。最近的研究表明,IL-15与其他细胞因子(如IL-6)协同作用,可增强CD8(+) T细胞不依赖T细胞受体(TCR)的增殖和功能。本研究的目的是探讨BaF3-mb15-RAE细胞在刺激小鼠CD8(+) T细胞中的作用。将BaF3细胞进行培养,B16F10细胞在DMEM中生长。采用MTT法检测CD8(+) T细胞的增殖。使用流式细胞术对细胞进行分析。结果表明,IL-15与另一种T细胞刺激分子RAE1ɛ协同作用,在不通过TCR信号传导的情况下,有力地促进CD8(+) T细胞的增殖,诱导CD8(+) T细胞活化,并增强颗粒酶B和干扰素-γ(IFN-γ)的产生。此外,IL-15与RAE1ɛ联合对CD8(+) T细胞介导的针对B16F10肿瘤细胞的细胞毒性产生协同作用。因此,本研究结果表明,IL-15与RAE1ɛ协同作用可增强体外CD8(+) T细胞不依赖TCR的效应功能,这可能在癌症的细胞免疫治疗中有用。

相似文献

1
IL-15, in synergy with RAE-1ɛ, stimulates TCR-independent proliferation and activation of CD8(+) T cells.白细胞介素-15与RAE-1ɛ协同作用,刺激CD8(+) T细胞的非T细胞受体依赖性增殖和活化。
Oncol Lett. 2012 Feb;3(2):472-476. doi: 10.3892/ol.2011.495. Epub 2011 Nov 25.
2
IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes.白细胞介素-6与白细胞介素-7或白细胞介素-15协同作用,刺激CD8 + T淋巴细胞的非T细胞受体依赖性增殖和功能分化。
J Immunol. 2008 Jun 15;180(12):7958-68. doi: 10.4049/jimmunol.180.12.7958.
3
Construction of a plasmid for co-expression of mouse membrane-bound form of IL-15 and RAE-1ε and its biological activity.构建共表达小鼠膜结合型 IL-15 和 RAE-1ε 的质粒及其生物学活性。
Plasmid. 2011 May;65(3):239-45. doi: 10.1016/j.plasmid.2011.02.004. Epub 2011 Mar 4.
4
Synergistic effects of IL-7 and IL-12 on human T cell activation.白细胞介素-7和白细胞介素-12对人T细胞活化的协同作用。
J Immunol. 1995 May 15;154(10):5093-102.
5
Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model.在鼠乳腺癌模型中,白细胞介素-7通过诱导γ干扰素增强肿瘤反应性CD8+ T细胞的体内抗肿瘤活性。
Asian Pac J Cancer Prev. 2014;15(1):265-71. doi: 10.7314/apjcp.2014.15.1.265.
6
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.异二聚体 IL-15 通过涉及 XCL1、IFN-γ、CXCL9 和 CXCL10 的细胞因子网络延迟肿瘤生长并促进肿瘤内 CTL 和树突状细胞积累。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000599.
7
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.IL-21与IL-15在调节CD8+ T细胞扩增和功能方面的协同作用。
J Exp Med. 2005 Jan 3;201(1):139-48. doi: 10.1084/jem.20041057.
8
Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.IL-27通过增强颗粒酶B表达增强效应性CD8+ T细胞生成。
J Immunol. 2005 Aug 1;175(3):1686-93. doi: 10.4049/jimmunol.175.3.1686.
9
Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.自然杀伤(NK)细胞刺激因子或白细胞介素-12对TCR-αβ +、TCR-γδ + T淋巴细胞和NK细胞的增殖具有不同的作用。
J Immunol. 1992 Dec 1;149(11):3495-502.
10
Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.白细胞介素-2或白细胞介素-15在无抗原情况下诱导颗粒酶B和T细胞细胞毒性能力:多克隆反应,若被触发则具有极强的细胞溶解作用,且在细胞因子撤除后持续时间短暂。
Cytokine. 2006 Nov;36(3-4):148-59. doi: 10.1016/j.cyto.2006.11.008. Epub 2006 Dec 22.

引用本文的文献

1
Spatiotemporal transformable nano-assembly for on-demand drug delivery to enhance anti-tumor immunotherapy.用于按需给药以增强抗肿瘤免疫治疗的时空可转换纳米组装体。
Asian J Pharm Sci. 2024 Feb;19(1):100888. doi: 10.1016/j.ajps.2024.100888. Epub 2024 Feb 14.
2
NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice.自然杀伤细胞2D配体RAE1ε诱导小鼠骨髓来源抑制细胞的产生并增强其抑制功能。
J Cell Mol Med. 2017 Sep;21(9):2046-2054. doi: 10.1111/jcmm.13124. Epub 2017 Mar 9.

本文引用的文献

1
Construction of a plasmid for co-expression of mouse membrane-bound form of IL-15 and RAE-1ε and its biological activity.构建共表达小鼠膜结合型 IL-15 和 RAE-1ε 的质粒及其生物学活性。
Plasmid. 2011 May;65(3):239-45. doi: 10.1016/j.plasmid.2011.02.004. Epub 2011 Mar 4.
2
Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.成熟的自然杀伤细胞在持续受到 IL-15/IL-15Ralpha 复合物刺激时会发生表型和功能改变,并不断积累。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21647-52. doi: 10.1073/pnas.1012128107. Epub 2010 Nov 22.
3
Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.转呈:调节白细胞介素-15 传递和反应的新机制。
Immunol Lett. 2010 Jan 4;127(2):85-92. doi: 10.1016/j.imlet.2009.09.009. Epub 2009 Oct 7.
4
Cytokine synergy in antigen-independent activation and priming of naive CD8+ T lymphocytes.细胞因子在初始CD8 + T淋巴细胞的抗原非依赖性激活和启动中的协同作用。
Crit Rev Immunol. 2009;29(3):219-39. doi: 10.1615/critrevimmunol.v29.i3.30.
5
Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.通过IL-15经β链/共同γ链信号转导激活的NK1.1⁺细胞和CD8⁺T细胞对肿瘤生长的抑制作用。
J Immunol. 2008 Dec 15;181(12):8237-47. doi: 10.4049/jimmunol.181.12.8237.
6
Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy.靶向先天免疫和适应性免疫的佐剂协同作用以增强肿瘤免疫治疗。
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16683-8. doi: 10.1073/pnas.0805054105. Epub 2008 Oct 20.
7
Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.细胞因子对CD8 + T淋巴细胞的抗原非特异性激活:与免疫、自身免疫和癌症的相关性。
Arch Immunol Ther Exp (Warsz). 2008 Sep-Oct;56(5):311-23. doi: 10.1007/s00005-008-0033-2.
8
Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation.树突状细胞通过白细胞介素-15转递呈递来驱动记忆性CD8 T细胞的稳态。
Blood. 2008 Dec 1;112(12):4546-54. doi: 10.1182/blood-2008-05-156307. Epub 2008 Sep 23.
9
NKG2D ligands: key targets of the immune response.NKG2D配体:免疫反应的关键靶点。
Trends Immunol. 2008 Aug;29(8):397-403. doi: 10.1016/j.it.2008.04.007. Epub 2008 Jul 3.
10
IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes.白细胞介素-6与白细胞介素-7或白细胞介素-15协同作用,刺激CD8 + T淋巴细胞的非T细胞受体依赖性增殖和功能分化。
J Immunol. 2008 Jun 15;180(12):7958-68. doi: 10.4049/jimmunol.180.12.7958.